View Author
cancer patient level breast plasminogen tissue activator protein tumor breast cancer study expression factor inhibitor biomarker urokinase-type plasminogen activator treatment tumour concentration methylation prognostic response therapy system analysis status sample growth survival growth factor bcar 1 disease assay group marker pai ‑1 outcome urokinase-type spermatozoa value cortisol receptor carcinoma sepsis signi ficantly bcar 1 levels oocyte table pa system children activity breast cancer patients plasminogen activator inhibitor prostate mutation pws patients plasminogen activator system metastasi urokinase signi prostate cancer chemotherapy follicle result methylated fl uid promoter prognosis women plasma metyrapone test fication death association speci colorectal cancer patients oncol control trial
10 Most Recent Publications
|
Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
(Article)
Schmitt, M. Mengele, K. Napieralski, R. Magdolen, V. Reuning, U. Gkazepis, A. Sweep, F.C. Brünner, N. Foekens, J.A. Harbeck, N. |
2010-11-01
|
|
Application of tumour markers in clinical practice [Toepassing van tumormarkers in de klinische praktijk]
(Article)
Keuren, J.F.W. Thomas, C.M.G. Bonfrer, J.M. Sweep, F.C. Boonstra, J.G. |
2010-01-01
|
|
Methylated genes as new cancer biomarkers
(Article)
Duffy, M.J. Napieralski, R. Martens, J.W.M. Span, P.N. Spyratos, F. Sweep, F.C. Brünner, N. Foekens, J.A. Schmitt, M. |
2009-02-01
|
|
Review of the role of the plasminogen activator system and vascular endothelial growth factor in subfertility
(Article)
Elbisch, I.M.W. Thomas, C.M.G. Wetzels, M. Willemsen, W.N.P. Sweep, F.C. Steegers-Theunissen, R.P.M. |
2008-12-01
|
|
Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA
(Article)
McKiernan, E. O'Brien, K. Sweep, F.C. Duffy, M.J. Grebenchtchikov, N. Geurts-Moespot, A. Sieuwerts, A.M. Martens, J.W.M. Magdolen, V. Evoy, D. McDermott, E. Crown, J. |
2008-11-04
|
|
High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome
(Article)
Lind van Wijngaarden, R.F.A. de Otten, B.J. Festen, D.A.M. Joosten, K.F.M. Jong, F.H. de Sweep, F.C. Hokken-Koelega, A.C.S. |
2008-05-01
|
|
Complex congenital malformations and the impact of the plasminogen activator system and β-hCG in amniotic fluid
(Article)
Verkleij-Hagoort , A.C. Ursem, N.T.C. Hop, W.C.J. Geurts-Moespot, A. Steegers-Theunissen, R.P.M. Sweep, F.C. Steegers-Theunissen, R.P.M. |
2007-11-01
|
|
Biomarkers for therapeutic efficacy
(Article)
Brünner, N. Vang Nielsen, K. Offenberg, H. Sweep, F.C. Martens, J.W.M. Foekens, J.A. Folprecht, G. Lutz, M.P. Mechetner, E. |
2007-09-01
|
|
Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis
(Article)
Emonts, M. Sweep, F.C. Calandra, T. Grebenchtchikov, N. Geurts-Moespot, A. Knaup, M. Chanson, A.L. Erard, V. Renner, P. Hermans, P.W.M. Hazelzet, J.A. |
2007-05-15
|
|
Possible role of the plasminogen activation system in human subfertility
(Article)
Elbisch, I.M.W. Steegers-Theunissen, R.P.M. Sweep, F.C. Zielhuis, G.A. Geurts-Moespot, A. Thomas, C.M.G. |
2007-03-01
|
